Want to see SABS full AI Analyst Report?
SAB Biotherapeutics (SABS) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| High Dose Sab-142, Low Dose Sab-142 | Type 1 Diabetes | Phase II | Not Yet Recruiting | SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes | Sep 08, 2025 | ― |
| Sab-176 | Influenza A H1n1 | Phase II | Completed | Study of SAB-176 in Healthy Adult Participants | Apr 06, 2021 | ― |
| Normal Saline, Sab-176 | Influenza, Influenza Type A, Influenza Type B | Phase I | Completed | Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants | Jul 10, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| High Dose Sab-142, Low Dose Sab-142 | Phase II | Type 1 Diabetes | Not Yet Recruiting | SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes | Sep 08, 2025 | ― |
| Sab-176 | Phase II | Influenza A H1n1 | Completed | Study of SAB-176 in Healthy Adult Participants | Apr 06, 2021 | ― |
| Normal Saline, Sab-176 | Phase I | Influenza, Influenza Type A, Influenza Type B | Completed | Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants | Jul 10, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sab Biotherapeutics, Inc. (SABS) have in its pipeline
SAB Biotherapeutics SABS is currently developing the following drugs: High Dose Sab-142, Low Dose Sab-142, Sab-176, Normal Saline, Sab-176. These drug candidates are in various stages of clinical development as the company works toward FDA approval.